222 related articles for article (PubMed ID: 19904302)
1. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.
Williams SR; Mullegama SV; Rosenfeld JA; Dagli AI; Hatchwell E; Allen WP; Williams CA; Elsea SH
Eur J Hum Genet; 2010 Apr; 18(4):436-41. PubMed ID: 19904302
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental features in 2q23.1 microdeletion syndrome: report of a new patient with intractable seizures and review of literature.
Motobayashi M; Nishimura-Tadaki A; Inaba Y; Kosho T; Miyatake S; Niimi T; Nishimura T; Wakui K; Fukushima Y; Matsumoto N; Koike K
Am J Med Genet A; 2012 Apr; 158A(4):861-8. PubMed ID: 22407754
[TBL] [Abstract][Full Text] [Related]
3. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype.
van Bon BW; Koolen DA; Brueton L; McMullan D; Lichtenbelt KD; Adès LC; Peters G; Gibson K; Moloney S; Novara F; Pramparo T; Dalla Bernardina B; Zoccante L; Balottin U; Piazza F; Pecile V; Gasparini P; Guerci V; Kets M; Pfundt R; de Brouwer AP; Veltman JA; de Leeuw N; Wilson M; Antony J; Reitano S; Luciano D; Fichera M; Romano C; Brunner HG; Zuffardi O; de Vries BB
Eur J Hum Genet; 2010 Feb; 18(2):163-70. PubMed ID: 19809484
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder.
Mullegama SV; Rosenfeld JA; Orellana C; van Bon BW; Halbach S; Repnikova EA; Brick L; Li C; Dupuis L; Rosello M; Aradhya S; Stavropoulos DJ; Manickam K; Mitchell E; Hodge JC; Talkowski ME; Gusella JF; Keller K; Zonana J; Schwartz S; Pyatt RE; Waggoner DJ; Shaffer LG; Lin AE; de Vries BB; Mendoza-Londono R; Elsea SH
Eur J Hum Genet; 2014 Jan; 22(1):57-63. PubMed ID: 23632792
[TBL] [Abstract][Full Text] [Related]
5. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
[TBL] [Abstract][Full Text] [Related]
6. 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.
Noh GJ; Graham JM
Eur J Med Genet; 2012 May; 55(5):354-7. PubMed ID: 22659271
[TBL] [Abstract][Full Text] [Related]
7. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features.
Chung BH; Stavropoulos J; Marshall CR; Weksberg R; Scherer SW; Yoon G
Am J Med Genet A; 2011 Feb; 155A(2):424-9. PubMed ID: 21271666
[TBL] [Abstract][Full Text] [Related]
8. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.
Ballif BC; Rosenfeld JA; Traylor R; Theisen A; Bader PI; Ladda RL; Sell SL; Steinraths M; Surti U; McGuire M; Williams S; Farrell SA; Filiano J; Schnur RE; Coffey LB; Tervo RC; Stroud T; Marble M; Netzloff M; Hanson K; Aylsworth AS; Bamforth JS; Babu D; Niyazov DM; Ravnan JB; Schultz RA; Lamb AN; Torchia BS; Bejjani BA; Shaffer LG
Hum Genet; 2012 Jan; 131(1):145-56. PubMed ID: 21800092
[TBL] [Abstract][Full Text] [Related]
9. Severe intellectual disability and autistic features associated with microduplication 2q23.1.
Chung BH; Mullegama S; Marshall CR; Lionel AC; Weksberg R; Dupuis L; Brick L; Li C; Scherer SW; Aradhya S; Stavropoulos DJ; Elsea SH; Mendoza-Londono R
Eur J Hum Genet; 2012 Apr; 20(4):398-403. PubMed ID: 22085900
[TBL] [Abstract][Full Text] [Related]
10. 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.
Noh GJ; Graham JM
Eur J Med Genet; 2012 Jan; 55(1):59-62. PubMed ID: 22085995
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.
Mullegama SV; Alaimo JT; Chen L; Elsea SH
Int J Mol Sci; 2015 Apr; 16(4):7627-43. PubMed ID: 25853262
[TBL] [Abstract][Full Text] [Related]
12. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.
Talkowski ME; Mullegama SV; Rosenfeld JA; van Bon BW; Shen Y; Repnikova EA; Gastier-Foster J; Thrush DL; Kathiresan S; Ruderfer DM; Chiang C; Hanscom C; Ernst C; Lindgren AM; Morton CC; An Y; Astbury C; Brueton LA; Lichtenbelt KD; Ades LC; Fichera M; Romano C; Innis JW; Williams CA; Bartholomew D; Van Allen MI; Parikh A; Zhang L; Wu BL; Pyatt RE; Schwartz S; Shaffer LG; de Vries BB; Gusella JF; Elsea SH
Am J Hum Genet; 2011 Oct; 89(4):551-63. PubMed ID: 21981781
[TBL] [Abstract][Full Text] [Related]
13. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.
Mullegama SV; Pugliesi L; Burns B; Shah Z; Tahir R; Gu Y; Nelson DL; Elsea SH
Eur J Hum Genet; 2015 Jun; 23(6):781-9. PubMed ID: 25271084
[TBL] [Abstract][Full Text] [Related]
14. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
[TBL] [Abstract][Full Text] [Related]
15. Extended spectrum of MBD5 mutations in neurodevelopmental disorders.
Bonnet C; Ali Khan A; Bresso E; Vigouroux C; Béri M; Lejczak S; Deemer B; Andrieux J; Philippe C; Moncla A; Giurgea I; Devignes MD; Leheup B; Jonveaux P
Eur J Hum Genet; 2013 Dec; 21(12):1457-61. PubMed ID: 23422940
[TBL] [Abstract][Full Text] [Related]
16. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
[TBL] [Abstract][Full Text] [Related]
17. A cryptic microdeletion including MBD5 occurring within the breakpoint of a reciprocal translocation between chromosomes 2 and 5 in a patient with developmental delay and obesity.
Shichiji M; Ito Y; Shimojima K; Nakamu H; Oguni H; Osawa M; Yamamoto T
Am J Med Genet A; 2013 Apr; 161A(4):850-5. PubMed ID: 23494922
[TBL] [Abstract][Full Text] [Related]
18. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay.
Burnside RD; Pasion R; Mikhail FM; Carroll AJ; Robin NH; Youngs EL; Gadi IK; Keitges E; Jaswaney VL; Papenhausen PR; Potluri VR; Risheg H; Rush B; Smith JL; Schwartz S; Tepperberg JH; Butler MG
Hum Genet; 2011 Oct; 130(4):517-28. PubMed ID: 21359847
[TBL] [Abstract][Full Text] [Related]
19. 109 kb deletion of chromosome 4p16.3 in a patient with mild phenotype of Wolf-Hirschhorn syndrome.
Okamoto N; Ohmachi K; Shimada S; Shimojima K; Yamamoto T
Am J Med Genet A; 2013 Jun; 161A(6):1465-9. PubMed ID: 23637096
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
